Clayton Pharmaceuticals gains FDA nod for generic sucralfate oral suspensionSucralfate Oral Suspension had a market value of $188.5 million, of which $157.9 million represents generic sales, for the 12 months ending December 2021, according to IQVIA. Eton gains FDA nod for generic ElcysCysteine injection has a market value of $50 million annually, according to IQVIA. Alembic Pharma buys out partner stake in Aleor Dermaceuticals The acquisition is intended to strengthen Alembic's skin-related manufacturing and marketing footprint. AbbVie’s Allergan reportedly files lawsuits over proposed generic Viberzi MSN Labs and Sun Pharmaceutical are the only remaining defendants in a related consolidated case. Dr. Reddy’s launches generic Solu-Medrol Dr. Reddy's generic Solu-Medrol provides treatment for arthritis, blood disorders and severe allergic reactions. Elite, Praxgen gain FDA OK for generic doxycycline Doxycycline Hyclate is an antibiotic that is used to treat a wide variety of bacterial infections. Aurobindo receives FDA nod for generic Zovirax Acyclovir oral suspension has a market value of roughly $10.4 million for the 12 months ending February 2022, according to IQVIA. ANI welcomes new board member With Renee Tannenbaum's appointment, ANI’s board of directors totals nine members. Hikma debuts benztropine mesylate in vial format The medication is indicated as an adjunct in the therapy of all forms of Parkinsonism. Mayne Pharma adds board member Custin, a U.S. resident, has almost 40 years of experience in the healthcare sector. First Previous 81 82 83 84 85 Next Last